Studies have shown that the expression of GZMB is elevated in skin lesions and plasma of psoriasis patients (Yawalkar et al., 2001; Kamata et al., 2016), suggesting that GzmB may be involved in CD8+ T cell-mediated cell damage and inflammation. This evidence concerns the gene CD8A and psoriasis.